Results 121 to 130 of about 102,163 (289)

Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts [PDF]

, 2009
Emmanouil S. Brilakis, Subhash Banerjee, William Lombardi   +2 more
openalex   +1 more source

Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study [PDF]

, 2020
Yong Wang, Hongwei Zhao, Chengfu Wang, Xiaojiao Zhang, Jie Tao, Chun-sheng Cui, Qing-kun Meng, Yu Zhu, Defeng Luo, Aijie Hou, Bo Luan   +10 more
openalex   +1 more source

Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo‐controlled, crossover trial

European Journal of Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a major healthcare burden with limited treatment options. Geranylgeranylacetone (GGA) has been shown to improve myocardial compliance and endothelial function in preclinical models.
Soufiane Nassiri, Geert H.D. Voordes, Loek van Heerebeek, Daniël H. van Raalte, Marianne C. Verhaar, Daan J. Touw, Merle M. Krebber, Dirk J. Duncker, Etto C. Eringa, M. Louis Handoko, Adriaan A. Voors, on behalf of the RECONNEXT Consortium   +11 more
wiley   +1 more source

Late onset branch retinal artery occlusion following coronary angiography [PDF]

, 2005
George D. Kymionis, Miltiadis K. Tsilimbaris, Emmanuel B. Christodoulakis, Ioannis G. Pallikaris   +3 more
openalex   +1 more source

Impact of genotype–phenotype associations on prognosis in dilated cardiomyopathy

European Journal of Heart Failure, EarlyView.
Prediction of clinical outcomes in genetic dilated cardiomyopathy (DCM). LVEF, left ventricular ejection fraction. Aims Dilated cardiomyopathy (DCM) has a monogenic aetiology in up to 40% of patients. Understanding the spectrum of genotype–phenotype associations in DCM is crucial for risk stratification and personalized treatment.
Sophie L.V.M. Stroeks, Ping Wang, Marco Merlo, Steven Muller, Alessia Paldino, Nerea Mora‐Ayestaran, Max Jason, Matteo dal Ferro, Carola Pio Loco detto Gava, Fernando Dominguez, Esther Gonzalez‐Lopez, Arthur van den Wijngaard, Max F.G.H.M. Venner, Maurits Sikking, Michiel Minten, Bastien Nihant, Nina Beelen, Sharon Graw, Kristen Medo, Bart de Koning, Matthew Taylor, J. Peter van Tintelen, Luisa Mestroni, Gianfranco Sinagra, Anneline S.J.M. te Riele, Pablo Garcia‐Pavia, Stephane Heymans, Job A.J. Verdonschot   +27 more
wiley   +1 more source

Do we need a new score in order to perform a contemporary percutaneous coronary intervention of a chronic total occlusion?

, 2020
João Brum da Silveira
openalex   +1 more source

Metabolic Signatures and Diagnostic Prediction Models for Coronary Artery Disease and Type 2 Diabetes Mellitus: Insights From an Exploratory Study

iNew Medicine, EarlyView.
Metabolomic & lipidomic analysis reveals metabolic overlap between CAD & T2DM, highlighting 7 key metabolites as potential biomarkers. A predictive model based on these achieves high accuracy, potentially advancing precision medicine & metabolic insights.
Zhihua Wang, Meiming Su, Ying Li, Yapei Li, Shuo Chen, Ting Peng, Hans Strijdom, Jiangang Wang, Jianping Weng, Suowen Xu   +9 more
wiley   +1 more source

Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview [PDF]

, 2015
Alfredo R. Galassi, Emmanouil S. Brilakis, Marouane Boukhris, Salvatore D. Tomasello, Georgios Sianos, Dimitri Karmpaliotis, Carlo Di Mario, Bradley H. Strauss, Stéphane Rinfret, Masahisa Yamane, Osamu Katoh, Gerald S. Werner, Nicolaus Reifart   +12 more
openalex   +1 more source

Percutaneous coronary intervention for chronic total coronary occlusion: Do. Or do not. There is no try [PDF]

, 2020
Paul Knaapen, Josè P.S. Henriques, Alexander Nap, Fatih Arslan   +3 more
openalex   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source